IKS Health Shines with 60% PAT Growth in Q2 FY26

IKS Health, a technology-enabled healthcare solutions provider, reported substantial financial achievements in Q2 FY26, with a 22% increase in revenue, 43% in EBITDA, and 60% in PAT. These results highlight the success of its Care Enablement Platform in addressing healthcare's administrative, clinical, and financial challenges, alongside strategic partnerships.

Inventurus Knowledge Solutions Limited, known as IKS Health, reported outstanding financial results for the quarter ending September 30, 2025, with a notable increase in revenue, EBITDA, and PAT. This growth reflects the company's strong market position and the rising demand for its Care Enablement Platform.

IKS Health has continued to expand its influence through key strategic partnerships. Noteworthy collaborations include those with Advent Health, Revere Health, and The Jackson Clinic, which underline IKS Health's commitment to enhancing clinical efficiency and financial performance.

Recognized with several awards, including the Google Cloud DORA Award 2025, IKS Health remains dedicated to leveraging AI and innovative solutions to drive sustainable growth and operational excellence in healthcare.

(With inputs from agencies.)